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Background:  Ketamine  is  a controlled  substance  and  often  illegally  used  as  a recreational
drug  primarily  by  young  adults.  Increasing  ketamine  abusers  associated  with  lower  urinary
tract symptoms  have  been  reported  at hospitals  in  recent  years.  Here  we  used  a murine
model to explore  the  changes  of bladder  in  order  to elucidate  its pathogenesis.
Methods:  ICR  mice  were  randomly  distributed  into  control  and ketamine  groups  and
received  daily  intraperitoneal  injection  of saline  and  ketamine  (30  mg/kg),  respectively.
The  bladders  were  excised  and  processed  for histology  at 4, 8  and  12  weeks.  Tryptase  and
E-cadherin were  investigated  by  immunohistochemistry  in  bladder  tissues  from  ketamine-
treated  and  control  mice  to  assess  the  mast  cell  activation  and  junction  protein  expression.
Results:  After  ketamine  treatment,  the  bladder  changed  to  be  hyperemic,  inﬂamed,  and  with
more ﬁssures  in  mucosa.  Compared  with  control  group,  the  number  of  tryptase-positive
mast  cells  signiﬁcantly  increased,  which  was  6.98 ±  2.89  and 23.00  ±  6.48  cells  per ﬁeld
(100×)  at  8  and  12 weeks,  respectively  (P =  0.016  and  P =  0.003,  respectively).  Additionally,
the  expression  of  E-cadherin  in ketamine-treated  mice  bladder  tissue  was signiﬁcantly
lower  than  that  in  the  control  tissues,  P <  0.001.
Conclusions:  Increased  mast  cells  in bladder  wall  and  downregulated  expression  of  E-
cadherin junction  protein  in  epithelial  cells  were  probably  associated  with  interstitialeywords:
etamine
ystitis
-cadherin
ladder
inﬂammation  and  ﬁssures  in mucosa.  It implied  that  ketamine  induced  an  interstitial  cys-
titis.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).ice
. IntroductionKetamine is currently used as an injectable anesthetic
n hospitals. In contrast to medical use, it is also abused
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http://creativecommons.org/licenses/by-nc-nd/3.0/).by young adults in clubs. Illicit use of ketamine has been
reported to produce adverse effects on the urinary tract [1],
particularly the bladder [2–5]. Symptoms of long term use
include dysuria, urgency, nocturia, urothelial ulceration,
etc., which are very similar to interstitial cystitis. To our
knowledge, how ketamine produces these lower urinary
tract symptoms is still not well known. Previous reports
have showed the mechanisms of it on the nervous system
and have linked it to the glutamatergic N-methyl-aspartate
is is an open access article under the CC BY-NC-ND license
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(NMDA) receptor [1,6–8]. Although, ketamine, as an NMDA
non-competitive antagonist, can induce neurons to com-
mit  apoptosis, the effect of ketamine on other organs of the
body is still far from clear.
Here, in a study of ketamine addiction induced mice
cystitis, we have observed histopathological changes
in the urinary bladders wall and urothelium, such as
immune cell inﬁltration, junction protein expression in
ketamine-treated bladder tissue. It maybe advances our
understanding of the bladder pathophysiology of ketamine
addiction.
2. Materials and methods
2.1. Animal breeding, ketamine treatment and tissue
sampling
A total of 27 ICR mice weighed 20 g were bought from
the Animal Center in Fujian Medical University and housed
under a 12-h light/dark cycle with free access to food and
water. All experimental protocols were approved by the
institutional animal care and use committee. These mice
(n = 6 for every time point) received daily intraperitoneal
injection of ketamine (30 mg/kg) to model the effects of
repeated ketamine abuse, or saline for normal subjects
(n = 3 for every time point). Each week the weight of the liv-
ing mice are weighed and recorded. After 4, 8 or 12 weeks,
mice were sacriﬁced. Their bladders were harvested and
ﬁxed in 4% formaldehyde solution at room temperature for
immunohistochemistry assay. If for electron microscopy,
the samples should be ﬁxed immediately by immersion
in 3% glutaradehyde plus 1.5% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.2 at 4 ◦C for later use.
2.2. Immunohistochemistry
Fixed tissue samples were processed for dehydration
in increasing concentrations of ethanol, two changes of
xylene, and embedded in parafﬁn wax. Afterwards, the
parafﬁn blocks were sectioned serially at 4 m using
leica 2235. When analyzed for mast cell tryptase activity
and E-cadherin expression, bladder tissue sections were
deparafﬁnized and rehydrated. Subsequently, immunore-
activity was detected using 1:100 dilution of puriﬁed rabbit
monoclonal anti-tryptase antibody (ab134932, Abcam Inc.)
and anti-E-cadherin monoclonal antibody (24E10, Cell Sig-
naling Technology Inc.) or normal rabbit IgG (as a control)
at 4 ◦C overnight, followed by incubation with peroxidase-
conjugated anti rabbit IgG for 1 h at room temperature
and reacted with DAB according to SABC kit guideline. All
stained sections were examined under light microscope.
Images were acquired using Olympus DP72. The integrated
optical density (IOD) was then measured using Image-
Pro plus 5.0 software. In addition, all serial sections were
stained with routine hematoxylin and eosin, washed by tap
water, dehydrated, and mounted with neutral gum.2.3. Electron microscopy
After 2 h ﬁxation at 4 ◦C as described above, the tissue
samples were washed 3 times with PBS and trimmed intots 2 (2015) 205–209
small pieces, then postﬁxed with 1% OsO4–1.5% potassium
ferrocyanide in phosphate buffer for 1.5 h. After 3 times
wash and dehydration in graded ethanol series, the speci-
mens was  embedded in epoxy resin. One micrometer thick
sections were ﬁrst examined by light microscopy in order
to locate the area of interest (semi thin section). These sec-
tions were cut using a Leica UC-6 ultramicrotome with
a diamond knife into ultrathin sections and mounted on
copper grids and were counterstained with uranyl acetate
and lead citrate, then examined by PHILIPS EM208 electron
microscope.
2.4. Statistical analysis
The data were presented as means ± standard
deviations. All data were analyzed using one-way
ANOVA test bilaterally. When signiﬁcance was found,
between-group differences were further analyzed by
Student–Newman–Keuls analysis. P values less than
0.05 were considered statistically signiﬁcant. SPSS 11.5
statistics software (SPSS, Chicago, IL, USA) was used for all
statistical analysis.
3. Results
3.1. Body weight changes of mice and general changes of
bladder
After treatment of ketamine, the mice showed promi-
nent swaying and ataxia in about 30 min. The increases in
body weight for both the ketamine and control groups were
similar at 4 and 8 weeks. But weight gain in ketamine-
treated mice became slower after 12 weeks. However,
the difference was not statistically signiﬁcant (data not
shown). The bladders in ketamine groups appeared hyper-
emic and inﬂamed (arrows indicating where the ketamine
tissue was  inﬂamed), compared with the normal bladders
in control group (Fig. 1A and C). The ketamine-treated
animals developed dramatically histological changes in
bladder. The bladder epithelia in the experimental mice
were impressed with more ulceration and ﬁssure than
those in control mice. Epithelium shedding was often
noted in the ketamine-treated bladders. Also, with HE
staining, ﬁssures of mucosa were calculated under light
microscopy. Compared with ﬁssures per ﬁeld in control
group (0.14 ± 0.35), ﬁssures in ketamine group increased at
4 weeks (0.18 ± 0.39), 8 weeks (0.21 ± 0.41), and especially
at 12 weeks (1.28 ± 1.15) (P < 0.001), respectively (Fig. 1B
and C).
3.2. Increased mast cells trypase enzymes
immunoreactivity
Tryptase-positive mast cells were found mainly in the
bladder wall of ketamine-treated mice and were observed
initially after 8 weeks of administration of ketamine. There
were sparsely one or no tryptase-positive cells in the
same place of control mouse. The numbers of tryptase-
positive mast cells in the ketamine group were 3.16 ± 2.71,
6.98 ± 2.89 and 23.00 ± 6.48 cells per ﬁeld (100×) at 4,
8 and 12 weeks, respectively. While the corresponding
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Fig. 1. Effect of ketamine treatment on bladder wall. (A) The normal gross bladder and blood congested ketamine-induced bladder. (B and C) Parafﬁn
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mections of bladders in ICR mice, stained with hematoxylin–eosin, show
buse  resulted in remarkable increased ﬁssures in bladder mucosa, espe
riginal magniﬁcation 200×.
umbers in control groups were 1.29 ± 0.68, 1.17 ± 0.77
nd 2.67 ± 0.85 cells per ﬁeld. As shown in Fig. 2A and B,
here were signiﬁcant increases of tryptase-positive mast
ells at 8 and 12 weeks in ketamine group than those in
ontrol mice (P = 0.016 and P = 0.003, respectively). This
henomenon was also conﬁrmed by electron microscopy,
s presented in Fig. 2C.
.3. E-cadherin junction protein expression
The E-cadherin moleculars were widely distributed at
ell–cell junction in the superﬁcial layers of the urothe-
ium in normal state. The expression of E-cadherin in
etamine-treated mice bladder tissue was signiﬁcantly
ownregulated, compared with that in the control mice
P < 0.001). As shown in Fig. 3, the expression of E-cadherin
n the control group was standardized to be 100 ± 8.81, At 4,
 and 12 weeks, those in ketamine groups were decreased
o be 96.43 ± 5.77 (P = 0.41), 64.30 ± 8.36 (P < 0.001) and
7.25 ± 6.01 (P < 0.001), respectively.
. Discussion
Ketamine abuse has become more and more popular
n clubs for youngsters. Lower urinary tract damage
nd symptoms of cystitis were frequently reported in
iterature in recent years. To investigate the underlying
echanism, ketamine at 30 mg/kg was administeredphology of bladder tissue. Compared with the control group, ketamine
 12 weeks. *A signiﬁcant difference between “12 weeks” and the others.
interperitoneally (i.p.) to mice. Higher dosage
(60–150 mg/kg) could cause severe incordination of
hind limbs of mice and anesthetic effects according to doc-
uments [9]. At 4, 8 and 12 weeks, bladders were collected
and effects of this amount of ketamine on urinary bladder
morphology and histology were investigated ﬁrstly. As
expected, all specimens in experimental group were
characterized by apparent hyperemic mucosa lesions with
naked eyes. It was  further conﬁrmed by histology with
microscope. The mucosa had been ulcerated to ﬁssure and
was inﬁltrated of inﬂammatory cells surrounding the cap-
illaries. This resembles interstitial cystitis [10] in clinical
practice, which also has reddish dotted blood congestion
and bladder mucosal ulcerative damage [11,12] under
cystoscope. It indicated ketamine-treated mice bladder
was associated with interstitial inﬂammation and mucosa
damage, which demonstrated the successful mice model.
Which kind of immune cells involved in this process
was important. Previous reports about interstitial cystitis
showed mast cells could directly cause vasodilation and
bladder mucosa damage [12–14]. Immune staining using
antibodies against tryptase which presented in the gran-
ules of mast cells has been considered to be the most
preferential method for identiﬁcation of mast cells. In our
study we used this method to characterize the mast cell
inﬁltration in bladder tissue. Expectedly, mast cell counts
were elevated in the bladders of ketamine-treated mice
than in control mice. Electron microscopy also approved
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Fig. 2. Increased mast cells were observed in ketamine-treated mice bladder. (A and B) More tryptase-positive mast cells were identiﬁed as brown
 control
treated
agniﬁcparticles on ketamine-treated bladder wall sections compared with the
100×.  *P < 0.05. (C) Electron photomicrograph of mast cell on ketamine-
homogeneous electron-dense granules with speckled patterns. Original m
the existence of mast cells. These results suggest that mast
cells may  participate in bladder inﬂammation and con-
sequently play an important role in the pathogenesis of
bladder cystitis.
The urothelia serve as an effective blood–urine perme-
ability barrier to the penetration of urine into the bladder
stromal. The barrier function is maintained by tight junc-
tions that seal the space between adjacent superﬁcial cells.
Detection of E-cadherin is a valuable tool to investigate
cellular adhesion status of urothelium [11,15]. So recently
Lee reported that decreased expression of E-cadherin was
shown in ketamine-related cystitis of 16 patients [16].
It was coincidently consistent with our results in mice
Fig. 3. The expression of E-cadherin decreased in ketamine-treated bladder. (A) R
group and ketamine group. (B) In ketamine-treated mice, especially at 8 and 12 w
bladder wall. The P value of * and ** were all no more than 0.001. Original magniﬁ group. Mast cells increased mainly at 8 and 12 weeks. All ﬁgures were
 mice bladder at 12 weeks. Note intact mast cell with cytoplasm full of
ation 6300×.
model and approved its importance. After 4 weeks of
daily ketamine injection, the mice started to show obvi-
ously decreased E-cadherin expression. Especially after 8
weeks and 12 weeks, the lost of E-cadherin was  grad-
ually aggravated. This suggests that ketamine showed
time-dependent effect to mice cystitis. In the long term,
decreased E-cadherin expression may  damage the layer of
the bladder mucosa and make it vulnerable for urine to
penetrate into the mucosa and cause inﬂammation.On the whole, the study of the model of ketamine-
treated mice demonstrated that ketamine induced cystitis
in a time-dependent manner. The more exposure time to
ketamine, the more changes to bladder wall and E-cadherin
epresentative E-cadherin immunostaining in bladder wall of the control
eeks, there was a signiﬁcant decrease of E-cadherin immunostaining on
cation 400×.
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xpression in mucosa occurred. Ketamine induced appar-
nt interstitial cystitis. Here we have developed a mice
odel that predicts what is observed in humans and that
t could then be used to further investigate mechanisms or
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